Clinical Research Organization

Two shareholders in a clinical research organization (CRO) retained Caliber to determine the fair market value of the company’s shares to assist in finalizing a buy/sell agreement. The CRO researches and develops clinical treatments for its external clients and internal development program.

The clients were adversarial and we were asked to provide a valuation for mediation purposes.